Loading company
Latest annual · FY2022
Millions- Operating income
- (37)
- Net income
- (34)
- Free cash flow
- (32)
Latest quarter · Q2 FY2023
Millions- Operating income
- (8)
- Net income
- (7)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2017 to FY2022
- n/m
ONCOSEC MEDICAL Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$37 million | -$48.4 million | 10-K 2022-10-31 · proof | |
| Net income | -$34.2 million | -$45.2 million | 10-K 2022-10-31 · proof | |
| Cash from operating activities | -$32.1 million | -$41.8 million | 10-K 2022-10-31 · proof | |
| Free cash flow | -$32.4 million | -$42.1 million | 10-K 2022-10-31 · proof | |
| Total assets | $21.9 million | $56.3 million | -61.1% | 10-K 2022-10-31 · proof |
| Total liabilities | $15.8 million | $18.2 million | -13.4% | 10-K 2022-10-31 · proof |
| Cash and cash equivalents | $12.3 million | $46 million | -73.2% | 10-K 2022-10-31 · proof |
- What was ONCOSEC MEDICAL Inc's operating income in fiscal 2022?
- ONCOSEC MEDICAL Inc reported operating income of -$37 million for fiscal 2022 (the year ended Jul 31, 2022), against -$48.4 million the year before. Source: the 10-K filed with the SEC on Oct 31, 2022. SEC
- What was ONCOSEC MEDICAL Inc's net income in fiscal 2022?
- ONCOSEC MEDICAL Inc reported net income of -$34.2 million for fiscal 2022 (the year ended Jul 31, 2022), against -$45.2 million the year before. Source: the 10-K filed with the SEC on Oct 31, 2022. SEC
- What was ONCOSEC MEDICAL Inc's cash from operating activities in fiscal 2022?
- ONCOSEC MEDICAL Inc reported cash from operating activities of -$32.1 million for fiscal 2022 (the year ended Jul 31, 2022), against -$41.8 million the year before. Source: the 10-K filed with the SEC on Oct 31, 2022. SEC
- What was ONCOSEC MEDICAL Inc's free cash flow in fiscal 2022?
- ONCOSEC MEDICAL Inc reported free cash flow of -$32.4 million for fiscal 2022 (the year ended Jul 31, 2022), against -$42.1 million the year before. Source: the 10-K filed with the SEC on Oct 31, 2022. SEC
- What are ONCOSEC MEDICAL Inc's total assets?
- As of Jul 31, 2022, ONCOSEC MEDICAL Inc reported total assets of $21.9 million, against $56.3 million a year earlier (-61.1%). Source: the 10-K filed with the SEC on Oct 31, 2022. SEC
- What are ONCOSEC MEDICAL Inc's total liabilities?
- As of Jul 31, 2022, ONCOSEC MEDICAL Inc reported total liabilities of $15.8 million, against $18.2 million a year earlier (-13.4%). Source: the 10-K filed with the SEC on Oct 31, 2022. SEC
- What are ONCOSEC MEDICAL Inc's cash and cash equivalents?
- As of Jul 31, 2022, ONCOSEC MEDICAL Inc reported cash and cash equivalents of $12.3 million, against $46 million a year earlier (-73.2%). Source: the 10-K filed with the SEC on Oct 31, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1444307&period_type=annual&limit=5"Information only, not investment advice.